Cost Effectiveness Analysis Of Evolocumab, A PCSK9...

Cost Effectiveness Analysis Of Evolocumab, A PCSK9 Inhibitor, From The US Societal Perspective

Innis, BD, Hay, JW
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.04.368
Date:
May, 2018
File:
PDF, 112 KB
english, 2018
Conversion to is in progress
Conversion to is failed